Medical Device CDMO Market Size, Share, Trends & Forecast
The Medical Device CDMO Market was valued at approximately USD 41.7 billion in 2025 and is projected to reach USD 65 billion by 2035, registering a CAGR of approximately 4.5% from 2026 to 2035. Increasing outsourcing of medical device manufacturing, rising regulatory requirements, technological advancements, and growing demand for personalized healthcare solutions are supporting market expansion.
Contract development and manufacturing organizations help medical device companies manage product development, manufacturing, assembly, packaging, and other specialized activities. Outsourcing allows manufacturers to focus on product innovation while relying on external partners for production expertise and regulatory support.
Surgical devices represent a major product category. The segment was valued at approximately USD 16 billion in 2024 and is projected to reach around USD 26 billion by 2035, supported by demand for advanced surgical technologies and minimally invasive procedures.
Automation and artificial intelligence are transforming CDMO operations. Automated manufacturing systems and AI-enabled quality-control processes can improve production efficiency, consistency, and time-to-market.
Personalized healthcare and wearable technologies are also encouraging CDMOs to develop flexible manufacturing capabilities. These trends require specialized materials, advanced production processes, and strong regulatory expertise.
As medical device companies increasingly outsource complex manufacturing activities, CDMOs with scalable production capabilities, technology expertise, and regulatory knowledge are expected to gain new opportunities worldwide.